See All Slides - tctmd.com

Slides

Presentation TCT 2017

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Presenter: Gilles Dreyfus, Sanjay Kaul, Hendrik Treede

November 01, 2017

Presentation TCT 2017

New POT Strategy: POT and Re-POT

Presenter: Alejandro Cherro, Carlos Alejandro Alvarez

November 01, 2017

Presentation TCT 2017

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use PRO!

Presenter: Nick Curzen, Fausto Feres, Robert F. Riley

November 01, 2017

Presentation TCT 2017

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Presenter: Irene M. Lang, Ehtisham Mahmud, Hang Zhang

November 01, 2017

Presentation TCT 2017

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer

November 01, 2017

Presentation TCT 2017

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Presenter: Steven R. Bailey, Patrick W. Serruys, Angelo Biviano, MD

November 01, 2017

Presentation TCT 2017

Developing a STEMI System of Care for Low and Middle Income Countries: The STEMI India Model

Presenter: Vinay K. Bahl, Alice K. Jacobs, Thomas Alexander

November 01, 2017

Presentation TCT 2017

Integrated Anatomical and Functional Assessment of Coronary Artery Stenosis

Presenter: Pamela S. Douglas, Jonathon A. Leipsic, James K. Min, Manesh R. Patel

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Frederick Feit

November 01, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Advertisement

Slides

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

New POT Strategy: POT and Re-POT

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use PRO!

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Developing a STEMI System of Care for Low and Middle Income Countries: The STEMI India Model

Integrated Anatomical and Functional Assessment of Coronary Artery Stenosis

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content